Business Wire

Cell>Point and HYUN IMC Expand License in South Korea to Include Hanmi Pharmaceutical Co., Ltd for Cancer and Heart Disease Imaging | Business Wire

CENTENNIAL, Colo.--(BUSINESS WIRE)--Cell>Point announced today that it entered into a license agreement on December 17, 2012 with Hanmi Pharmaceutical Co., Ltd (Hanmi) who is headquartered in Seoul, ...
Santa Barbara Independent

Cancer Foundation of Santa Barbara Funds Digital SPECT/CT Device, Improving Patient Care and Reducing Wait Times

Press releases are posted on Independent.com as a free community service. Santa Barbara, CA- Since 2020, the Cancer Foundation of Santa Barbara has invested more than $10M into the Nuclear Medicine ...
News Medical

MILabs’ U-SPECT⁷/CT: Ultra-High Resolution Imaging for Advanced Preclinical Research

U-SPECT 7 CT from MILabs (a Rigaku company) offers unmatched preclinical dynamic and whole-body Single Photon Emission Computed Tomography (SPECT) performance, integrated with diagnostic micro-CT.
iaea.org

Clinical Applications of SPECT–CT

Single photon emission computed tomography (SPECT) has been used in routine diagnostic applications and in research since the 1980s. In the following decades, as the clinical application of hybrid ...